medline.ch Gynäkologie Mammae

	Diagnostic and prognostic values of differentially expressed genes in canine mammary carcinoma: An integrated bioinformatics analysis. PLoS One Rodríguez-Bejarano OH, Padilla DS, Alzate D, Botero L, Hernández GV, López-Kleine L, Patarroyo MA, Parra-Lopez CA. PMID: 42475371 [PubMed - indexed for MEDLINE]
	Diagnostic Efficacy of Contrast-Enhanced Ultrasound for Breast Intraductal Lesions: A Multi-Modal Physician Experience Study. J Ultrasound Med Yang Q, Gou T, Jia M, Cai L, Wang S, Yi R, Zheng Y, Zhang Y, Luo Y. PMID: 42475158 [PubMed - as supplied by publisher]
	Digital Mental Health Treatment and Symptoms of Depression and Anxiety in Breast Cancer Survivors: A Randomized Clinical Trial. JAMA Netw Open Chow PI, You W, Shaffer KM, Cohn WF, Showalter SL, Orange C, Ritterband LM, Mohr DC. PMID: 42475097 [PubMed - indexed for MEDLINE]
	Real-world treatment patterns and outcomes in hormone receptor-positive, HER2-low metastatic breast cancer, 2018-2023: a retrospective, observational, US cohort study. Breast Cancer Res Treat Mayer EL, Collin SM, Hillman S, Berrocal-Almanza LC, Sparano J, Lam C. PMID: 42474828 [PubMed - indexed for MEDLINE]
	Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study. Breast Cancer Res Treat Krasnow NA, Salans M, Jayaraj M, Kuwahara K, Zhou MH, Boreta L, Braunstein SE, Aghi MK, Chien J, Rugo H, Melisko ME, Morshed RA, Vasudevan HN, Huppert LA. PMID: 42474755 [PubMed - indexed for MEDLINE]
	Factors influencing discussion duration in breast cancer multidisciplinary team meetings: insights for streamlining care. Breast Cancer Res Treat Ko, Sanderink WBG, Prokop M, Mann RM. PMID: 42474586 [PubMed - indexed for MEDLINE]
	Abemaciclib rechallenge after progression on abemaciclib plus endocrine therapy in patients with hormone receptor-positive HER2-negative metastatic breast cancer: results from the phase II again study (WJOG14220B). Breast Cancer Res Treat Nishimura M, Kogawa T, Sugiyama K, Ozaki Y, Tanabe Y, Funasaka C, Kurozumi S, Yoshimura A, Iwasa T, Sakai H, Morita M, Watanabe S, Fujii T, Yamamoto M, Tsuji Y, Terada M, Ota T, Tokunaga S, Shimokawa M, Takano T. PMID: 42474572 [PubMed - indexed for MEDLINE]
	Dynamic evolution, prediction and patient stratification of chemotherapy-induced neutropenia in a predominantly breast cancer cohort: A decision-support study for building a bundle care strategy. Pak J Pharm Sci Dai S, Zhang X, Qiao Z, Li L, Ye L. PMID: 42474161 [PubMed - indexed for MEDLINE]
	Long-Term Dietary Changes and Mortality among Participants of a Whole Food Plant-Based Pilot Study for Metastatic Breast Cancer. Curr Dev Nutr Campbell TM, Campbell EK, Blanchard LM, Wixom N, Spath KM, Peppone LJ. PMID: 42473551 [PubMed]
	Non-coding RNA-mediated ferroptosis reprogramming in doxorubicin-resistant breast cancer: mechanistic evidence, subtype vulnerabilities, and translational strategies. World J Surg Oncol Yu X, Xu A, Yao L, Huang X, Wang J, Li C, Fu D. PMID: 42472836 [PubMed - as supplied by publisher]
	Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison. Ann Surg Oncol Seto A, Port E, Bernik S, Sheng T, Balija T. PMID: 42472753 [PubMed - as supplied by publisher]
	The Role of Locoregional Treatment in Non-Progressive De Novo Metastatic Breast Cancer under Systemic Treatment: A Randomized Controlled Trial (LTMBC). Ann Surg Oncol Omranipour R, Eslami B, Alipour S, Nazarian N, Shahi F, Mirzania M, Mousavi K, Elahi A, Vasigh M. PMID: 42472751 [PubMed - as supplied by publisher]
	Biomimetic Nanoparticles for Metastatic Breast Cancer: Advancing Targeted Drug Delivery Beyond Conventional Nanomedicine. Crit Rev Oncol Hematol Rehman U, Dongsar TS, Dongsar TT, Hasan N, Ahmed FJ, Kesharwani P. PMID: 42472562 [PubMed - as supplied by publisher]
	ncRNA-driven regulation of PD-L1 in breast cancer: mechanisms of immune escape and therapeutic opportunities. Clin Exp Med Mardi A, Moghaddam SR, Motlagh AR, Mehmandar-Oskuie A. PMID: 42472410 [PubMed - as supplied by publisher]
	An evidence informed framework for artificial intelligence in rare breast cancers using small cohort validation synthetic data practices and clinical governance. Discov Oncol Alshreef BS. PMID: 42472394 [PubMed - as supplied by publisher]
	The role of (18)F-FDG PET/CT in the imaging of patients with breast cancer. Hell J Nucl Med Skoura E. PMID: 42472327 [PubMed - indexed for MEDLINE]
	Outcomes of Technically Optimal Intraoperative Radiation Therapy With Electrons Versus Whole-Breast External Beam Radiation in Suitable Patients With Breast Cancer. Adv Radiat Oncol Jitwatcharakomol T, Setakornnukul J, Chuthapisith S, Ratanawichitrasin A, Petsuksiri J, Thephamongkhol K. PMID: 42472265 [PubMed]
	Three-Dimensionally Printed, On-Demand, Patient-Specific Breast Models to Support Mastectomy Gross Examination: A Proof-of-Concept Study. Cureus Kousidis P, Syrnioti A, Pavlidou F, Pliachas M, Nikolaidou A. PMID: 42472156 [PubMed]
	The role of serologic biomarkers "liquid biopsy" in the fight against breast cancer: From biological foundations to clinical impact. iScience Li Y, Wang Y, Wang R, Liu Y, Pei J. PMID: 42472109 [PubMed]
	Immune-associated alternative splicing signatures define molecular subtypes in breast cancer. iScience Liu Y, Wang P, Yuan B, Zhou P, Sun Q. PMID: 42472092 [PubMed]

Artikel 1 - 20 / 220220

Seite 1 von 11011

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung